Alumis (ALMS) Interest & Investment Income (2023 - 2024)
Alumis (ALMS) posted quarterly Interest & Investment Income of $2.0 million for Q2 2024, up 116.54% year-over-year from $913000.0 in Q3 2023, and up 116.54% quarter-over-quarter from $913000.0 in Q2 2023.
Alumis (ALMS) Interest & Investment Income (2023 - 2024) Analysis & Trends
Alumis (ALMS) has reported Interest & Investment Income for 2 consecutive years, with $2.0 million the latest figure, recorded in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.32 Bn | 132.47 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.35 Bn | 58.16 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 63.15 Bn | 58.01 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.86 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 28.14 Mn |
| 7 | Royalty Pharma | 27.67 Bn | 26.83 Bn | - | 5.13 Mn |
| 8 | BioNTech SE | 27.52 Bn | 9.13 Bn | 668.28 Mn | 115.94 Mn |
| 9 | Insmed | 26.98 Bn | 25.82 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Alumis | 3.06 Bn | 2.56 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.98 Mn |
| Jun 30, 2023 | 913,000.00 |